HIV / AIDs - Thailand Medical News

HIV News: Yale Study Uncovers How HIV Binds To T Cells

Nikhil Prasad Dec 02, 2023 4 days ago

HIV News: In a significant leap forward in the ongoing battle against HIV, researchers at the Yale School of Medicine have recently revealed a detailed understanding of the intricate processes governing the early stages of HIV infection. Through the application of cutting-edge cryogenic electron tomography (cryo-ET), the study covered in this HIV News report, not only unraveled the complex interpl...

HIV News: Hong Kong Researchers Make Breakthrough In CD4+ T Cell Recovery Treatment By Using Nicotinamide Mononucleotide (NMN)

Nikhil Prasad Nov 21, 2023 15 days ago

HIV News: In the persistent battle against HIV, researchers in Hong Kong have unveiled a groundbreaking breakthrough that holds immense promise for transforming HIV treatment. The focus of this revolutionary stride is Nicotinamide Mononucleotide (NMN), a novel agent that exhibits potential in the recovery of CD4+ T cells. Covered in this HIV News report, this comprehensive study provides a detaile...

Stem Cells News: U.S. Study Shows That Overpriced Stem Cell Therapies To Treat Knee Pain Are Not As Effective As Ordinary Corticosteroid Injections!

Nikhil Prasad Nov 03, 2023 1 month ago

Stem Cells News: Osteoarthritis (OA) is a debilitating condition that affects millions of people worldwide, resulting in extensive joint damage and chronic pain. Despite the continuous advancements in diagnosis, medications, and short-term pain management solutions, the development of a disease-modifying OA drug has remained a formidable challenge. However, in recent years, stem cell therapy is be...

HIV News: Johns Hopkins University Develops New Single Injectable Hydrogel That Delivers HIV Antivirals Over 42 Days!

Nikhil Prasad Sep 26, 2023 2 months ago

HIV News: In a remarkable breakthrough, researchers at Johns Hopkins University have developed an innovative injectable hydrogel that has the potential to transform the treatment of HIV. This revolutionary hydrogel self-assembles under specific conditions and releases a controlled dose of the anti-HIV drug lamivudine over an extended period of six weeks. This development offers new hope to individ...

HIV News: Unveiling The Intricate Relationship Between HIV-1 Infection And Neurodegeneration

Thailand Medical News Team Aug 24, 2023 3 months ago

HIV News: The global impact of the human immunodeficiency virus type 1 (HIV-1) has been immense, with over 39 million people living with HIV at the end of 2022. While antiretroviral medications have improved the lives of many infected individuals, HIV-1's ability to enter the central nervous system in around 80% of cases often results in neurodegeneration, giving rise to HIV-associated neuroco...

HIV News: New Study Unravels the Intricate Pathway Of HIV Invasion Into The Cell Nucleus - A Glimpse Into New Avenues For AIDS Treatment

Thailand Medical News Team Aug 10, 2023 4 months ago

HIV News: In a groundbreaking study published on August 10, 2023, in the prestigious journal Nature Communications, scientists have unveiled a novel and previously undiscovered route through which the human immunodeficiency virus (HIV) infiltrates the nucleus of healthy cells, thereby initiating a cascade of events that can lead to the replication of the virus and subsequent infection of other cel...

HIV News: Study Finds That CHD1L Gene Found In People Of African Ancestries Limits HIV Replication!

Thailand Medical News Team Aug 06, 2023 4 months ago

HIV News: The fight against HIV has been ongoing for decades, but the virus remains a persistent global health challenge, affecting nearly 40 million individuals worldwide. Despite significant progress in treatment and access to therapies, HIV continues to impact millions of lives, with no vaccine or cure in sight. Latest HIV News reports show that HIV infections are rising once again due to compl...

HIV News: Chilean Health Authorities Warn Of Rising HIV Cases. Newly Identified HIV Cases Up By 7% In One Year!

TMN News Team Aug 01, 2023 4 months ago

HIV News: Chile, a vibrant and diverse South American country, is facing a concerning surge in HIV cases, with health authorities reporting a 7% increase in infections in just one year. According to the Institute of Public Health (ISP), 5,401 new HIV cases were confirmed in 2022, leading to 644 associated deaths, while an estimated 84,000 people are living with the disease. The data reveals the hi...

HIV News: Groundbreaking Study Unveils Dual Gene-Editing Approach In Conjunction With Antiretroviral Therapy For HIV Eradication

Thailand Medical - HIV News May 19, 2023 7 months ago

HIV News: In an unprecedented breakthrough, researchers from Temple University and the University of Nebraska Medical Center (UNMC) have successfully combined a dual gene-editing approach with antiretroviral therapy to effectively eliminate HIV infection in animal models. This potentially revolutionary treatment development, sets the stage for future research aiming at human trials, promising a si...

U.S. NIAID Study Reveals Shocking Insights into Rare Immune Disease Called Idiopathic CD4 Lymphocytopenia. Relevant For New SARS-CoV-2 Sublineages?

Medical News - Idiopathic CD4 Lymphocytopenia (ICL) May 09, 2023 7 months ago

Medical News: A groundbreaking 11-year study led by the U.S. National Institute of Allergy and Infectious Diseases that was initiated by Dr Anthony Fauci Nation has exposed shocking insights into idiopathic CD4 lymphocytopenia (ICL), a rare and obscure immune deficiency that leaves individuals susceptible to a myriad of infectious diseases, autoimmune diseases, and cancers. The study has ...

HIV Genomes in Monocytes - A New Target for HIV Eradication

HIV News - HIV Genomes in Monocytes Apr 12, 2023 8 months ago

HIV News: In the pursuit of HIV eradication, scientists have been examining various hiding places or reservoirs where the virus can store its genetic material. Recent research conducted by a team from Johns Hopkins Medicine has discovered evidence that HIV genomes can persist in a stable reservoir within circulating white blood cells called monocytes. This discovery may provide a new direction for...

Why Is No One Talking About The New Highly Virulent HIV Strain: VB Variant Detected in the Netherlands That Poses a Serious Threat!

HIV News Apr 05, 2023 8 months ago

HIV News: A new subtype of HIV-1 has emerged, causing rapid decline in immune system function and increasing vulnerability to AIDS and has now been found to have spread globally! Researchers have discovered a highly virulent variant of subtype-B HIV-1 circulating in the Netherlands, causing alarm in the medical community. This new HIV strain, known as the "VB variant," is...

BREAKING! HIV News: Scientists Discover That The Phytochemical Hopeaphenol Inhibits Reactivation Of HIV Viral Reservoirs!

HIV News - Hopeaphenol - Viral Reservoirs Mar 29, 2023 8 months ago

The Phytochemical Hopeaphenol , A Natural Stilbenoid, Inhibits HIV Transcription by Targeting Both PKC and NF-κB Signaling and Cyclin-Dependent Kinase 9 HIV News: A new breakthrough discovery in HIV research hold promise in enhancing the efficacy of current HIV treatments and improve the quality for individuals living with HIV. Researchers from the Wistar Institute, Philadelp...

HIV News: U.S. Study Discovers Two Different Reservoirs Of Latent HIV In Infected Individuals, Furthering Complicating The Search For A Cure!

HIV News - Two Separate Latent HIV Resevoirs Feb 01, 2023 10 months ago

HIV News: Researchers from the University Of North Carolina-United States have discovered that beside the CD4+ cells in blood and lymph tissues that serve as a reservoir for latent HIV, the T Cells in the CNS (Central Nervous System) are also another reservoir for latent HIV virus! This further adds to complications for researchers trying to find a cure for HIV. Typically, when individual...

HIV News: U.S. FDA Grants Gilead Sciences Approval For New Drug Sunlenca (Lenacapavir) To be Used To Treat Treatment Resistant HIV.

HIV News - U.S. FDA Approves Sunlenca (Lenacapavir) For Treatment Resistant HIV Dec 30, 2022 11 months ago

HIV News: The U.S. FDA has of the 22nd of December 2022 granted approval to Gilead Sciences for the usage of its new drug, Sunlenca (Lenacapavir) to treat treatment resistant HIV. https://www.fda.gov/news-events/press-announcements/fda-approves-new-hiv-drug-adults-limited-treatment-options Numerous recent HIV News coverages indicate that treatment resistant HIV is becoming a major problem...

HIV News: New Injectable HIV PrEP That Last For Two Months Costing US$3,700 Developed For HISO Sluts And Upmarket Social Escorts!

HIV News -Long Lasting PrEP Injectables Dec 01, 2022 1 year ago

HIV News: A new injectable PrEP to combat HIV infections and can last for two months has entered the market but unfortunately the cost of the drug was deliberately aimed at HISO sluts and upmarket prostitutes as it cost about US$3,800 per dose or over US$22,000 per person per year in the United States! The new injectable PrEP called CAB-LA or cabotegravir-long acting was developed and pat...

HIV News: Kings College London Study Validates That HIV Infections Increase Risk Of Cardiovascular Issues!

HIV News - Heart Issues And HIV Nov 29, 2022 1 year ago

HIV News: A new study review led by researchers from Kings College London British Heart Foundation Centre, School of Cardiovascular and Metabolic Medicine & Sciences -UK has found that HIV infections increase risk of cardiovascular issues! The study team warned that HIV-associated cardiovascular disease is increasing in prevalence, but its mechanisms remain poorly understood. T...

HIV News: Researchers Find That A Protein Complex Called SMC5/6 Allows HIV To Evade Antivirals And Immunity

HIV News - SMC5/6 Nov 26, 2022 1 year ago

HIV News: A new study by researcher from Duke University Medical Center, Durham, North Carolina – USA have found that a protein complex called SMC5/6 allows HIV to evade antivirals and immunity. To date, it is already known that after viral entry and reverse transcription, HIV-1 proviruses that fail to integrate are epigenetically silenced, but the underlying mechanism has remained ...

HIV News: American And Australian Scientists Discover That A HIV Protein Nef Causes Permanent Changes To Immune Cells, Leading To Chronic Inflammation!

HIV News - Chronic Inflammation Nov 23, 2022 1 year ago

HIV News: A new study by researchers from The George Washington University - USA, University of Melbourne - Australia and Massachusetts General Hospital, Harvard Medical School, Boston – USA have found that a HIV protein called Nef causes permanent changes to immune cells, leading to chronic inflammation and associated co-morbidities including cardiovascular issues. According to the...

John Hopkins Study Shows That HIV Patients With Moderately Low CD4 Cell Counts Risk Severe Breakthrough COVID-19 Infection

Source: Medical News - COVID-19 -HIV Oct 14, 2022 1 year ago

A new study led by researchers from Johns Hopkins Bloomberg School of Public Health has found that HIV patients with moderately low CD4 cell counts risk severe breakthrough COVID-19 infections. The study team said that understanding the severity of postvaccination SARS-CoV-2 (ie, COVID-19) breakthrough illness among individuals with HIV (PWH) can inform vaccine guidelines and risk-reducti...

BREAKING! U.S.NIH Study Warns Of Potetial Human Outbreak Of A New Primate Hemorrhagic Fever-Causing Arterivirus From Africa That Is Far Worse Than HIV!

Source: Medical News - Simian arteriviruses Oct 05, 2022 1 year ago

A new U.S. NIH sponsored study has shockingly found that a primate hemorrhagic fever-causing arterivirus from Africa has acquired the necessary mutations to cross over into the human species using the CD162 receptors for cellular entry. It should be noted that the African continent is a hub for various emerging pathogens and diseases and in fact, one theory that has not been properly expl...

BREAKING! Italian Study Validates Previous Claims That SARS-CoV-2 Infections Causes Immunodeficiency Conditions Worse Than HIV Infections!

Source: COVID-19 Induced Immunodeficiency Jun 19, 2022 1 year ago

COVID-19 Induced Immunodeficiency: When Thailand Medical News as early as April 2020 warned and highlighted studies that SARS-CoV-2 infections could cause immunodeficiency conditions similar to those seen in HIV infections, we were ridiculed by many Western media and so called Western ‘garbage’ experts and even labelled as fake news by various America social media platforms! https:/...

University Of Kansas Study Shockingly Reveals That The Envelope Protein Of SARS-Cov-2 Potently Inhibits HIV-1 Infection!

Source: SARS-CoV-2 - HIV Mar 30, 2022 2 years ago

A new study by researchers from University of Kansas Medical Center-USA has found that the envelope protein of SARS-Cov-2 potently inhibits HIV-1 infection! It has been found that the human coronavirus SARS-CoV-2 encodes for a small 75 amino acid transmembrane proteins known collectively as the envelope (E) protein. The E protein forms an ion channel, like the viroporins from human immunod...

BREAKING! New Highly Virulent HIV Variant Discovered In Netherlands That Is Now Spreading Around Europe! Beware Having Sex With The Dutch Or British!

Source: HIV-VB Variant Feb 04, 2022 2 years ago

VB HIV Variant: An international team of researchers led by Oxford University-UK And Stichting HIV Monitoring Research Institute-Netherlands have discovered an alarming new highly virulent HIV variant in Netherlands that is fast spreading around Europe. The new variant replicates faster causing high viral loads, attacks and depletes the CD4 cells more aggressively and rapidly, and was found t...

New Study Uncovers Similarities and Differences Between Similarities Between SARS-CoV-2 And HIV-1 Infections In Terms Of Cellular And Immune Responses

Source: SARS-CoV-2-HIV Jan 15, 2022 2 years ago

SARS-CoV-2-HIV: Researchers from University of Chicago-USA and Northwestern University, Chicago-USA have in a new study uncovered the similarities and differences between SARS-CoV-2 And HIV-1 infections in terms of cellular and immune responses. The key findings of the study show that: -Both COVID-19 and HIV-1+ patients show disease-specific inflammatory immune signatures -CO...

Anti-Inflammatory And Antioxidant Peptides Called ApoA-I Mimetic Peptides Derived From Tomato Extract Can Reduce Intestinal Inflammation Due To HIV

Source: Latest HIV News Jan 12, 2022 2 years ago

A new study by researchers from the University of California Los Angeles (UCLA) has found that ApoA-I mimetic peptides, a type of anti-inflammatory and antioxidant peptides derived from tomato extract can reduce intestinal inflammation related to being infected with HIV. There is a dire need for novel therapeutic strategies are to attenuate increased systemic and gut inflammation that contribute ...

Omicron Cases Increasing In Denmark, UK and US. Variant Now Found In Chile, Senegal and Tunisia. In All 45 Countries Have Detected The Omicron Variant

Source: Medical News - Omicron Updates Dec 06, 2021 2 years ago

Omicron Updates: While many countries around the world are still seeing new winter surges due to the Delta variant and its emerging sub-variants, the Omicron variant has now been detected in a total of 43 countries around the world and is causing an increase of cases in Denmark, UK and US via local transmissions. In France, the Delta variant is now causing a surge due to the emergence of n...

Swiss Study Reveals That Mutations At A Hotspot W152 Of The N-Terminal Domain (NTD) Of The SARS-CoV-2 Virus Is Driving Immune Evasion!

Source: SARS-CoV-2 Mutations-Immune Evasion Oct 25, 2021 2 years ago

SARS-CoV-2 Mutations-Immune Evasion: A new study by researchers from the Data Science Department, SOPHiA GENETICS-Switzerland has found that mutations at a hotspot W152 of the N-Terminal Domain (NTD) of the SARS-CoV-2 virus is driving immune evasion. The study team reported a striking increase in the frequency of recruitment of diverse substitutions at a critical residue (W152), positioned...

COVID-19 Warning! Case Studies Show That HIV Patients Contracting COVID-19 Are Ideal Vivo Laboratories For Creating Worrisome SARS-CoV-2 Mutations!

Source: HIV-COVID-19 Jul 10, 2021 2 years ago

HIV-COVID-19: Numerous case studies are emerging that special attention needs to be paid to HIV patients should they contract the COVID-19 disease as their immunocompromised conditions make them perfect ‘vivo laboratories’ for the SARS-CoV-2 to constantly mutate and develop more potent and worrisome mutations and resultant variants. In one case study published on a preprint server by ...

HIV News: International Study led By University Of Southern California Shows Degree Of Brain Damage Inflicted By Immunosuppression and HIV Viral Load

Source: HIV News Jan 17, 2021 3 years ago

HIV News: A new international study led by the University of Southern California, involving various other research entities including University of Cape Town-South Africa,Thai Red Cross AIDS Research Centre-Thailand, University of Amsterdam-Netherlands, Washington University School of Medicine-USA, Missouri University of Novi Sad-Serbia ,University of New South Wales-Australia, University of Calif...

HIV News: Dolutegravir The New HIV Wonder Drug Failing In Africa Due To HIV Drug Resistant Mutations

Source: HIV News Dec 15, 2020 3 years ago

HIV News: A new collaborative international HIV study has shown that Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa. The research finds that this so-called 'wonder drug' may be less effective in patients resistant to older drugs. The research findings were published in the peer reviewed journal: Nature Communications. ...

HIV News: New Guidelines For HIV Antiretroviral Treatment (ART) Will See Dolutegravir Prescribed For Individuals Newly Diagnosed With HIV

Source: HIV News Oct 19, 2020 3 years ago

HIV News: University of British Columbia researchers have concluded a new study of which the findings are set to change international treatment recommendations for individuals who are newly diagnosed with HIV, an update that could affect nearly two million people per year worldwide. The research found that the antiviral dolutegravir is the optimal medication for first-line treatment for i...

WARNING! Commonly Used HIV Drug Truvada Induces A Type I/III Interferon-Associated Signature And Inflammation Throughout The Gut

Source: HIV Drugs Sep 23, 2020 3 years ago

HIV Drugs: According to researchers from the University of Washington-Seattle, the commonly used HIV drug that is to treat those infected and also individuals using it as a prophylaxis or in PrEP protocols can induce a type I/III interferon-associated signature and inflammation throughout the gut. It should be noted that long term inflammation of any kind can lead to a variety of chronic ...

BREAKING! HIV News: Antibiotics Called Pleicomacrolides Allows Immune System To Kill HIV Infected Cells According to University Of Michigan Study

Source: HIV News Sep 08, 2020 3 years ago

HIV News: Researchers from University of Michigan Health System have discovered that a class of antibiotics called pleicomacrolides allows the immune system to kill HIV infected cells by inhibiting the Nef proteins. The research finds are published in the Journal of The Proceedings of the National Academy Of Sciences of The United States Of America (Concanamycin A counteracts HIV-1 Nef to...

HIV News: Another Long-Acting, Injectable Drug CPT31 That Last For 3 Months To Treat HIV Coming Soon.

Source: HIV News Aug 23, 2020 3 years ago

HIV News: The trend for HIV drug research is now shifting towards drugs with long lasting effects without the need for HIV patients to adhere to stringent daily regimens and doses which can be quiet stressful at times. Scientists from the University of Utah Health in collaboration with researchers from the National Institute of Allergy and Infectious Diseases (NIAID), Beth Israel Deacones...

HIV Drug News: Latest Study Shows Fingolimod, A Multiple-Sclerosis Drug Blocks HIV Infections And Eradicates Latent Virus Reservoirs

Source: HIV Drug News Aug 15, 2020 3 years ago

HIV Drug News: Researchers at the George Washington University in a new study have discovered that Fingolimod, a US FDA-approved immunosuppressive drug used to treat multiple sclerosis flare-ups, may be used to effectively block HIV infection and reduce the latent virus reservoir. The research findings were published in the journal: PLOS Pathogens. https://journals.plos.org/plospathogens/...

HIV Research: Study Warns That People Living Longer With HIV At Risk Of Myocardial Steatosis, Heart Failure, Kidney Damage And Other Health Issues

Source: HIV Research Aug 02, 2020 3 years ago

HIV Research: The significant impact and prevalence of heart disease and other critical comorbidities on an aging global population with human immunodeficiency virus (HIV) have emerged from a suite of articles in The Journal of Infectious Diseases that contains the first swath of important data from the world's largest study of cardiovascular disease (CVD) prevention in people with H...

COVID-19 And HIV: Icahn Researchers Say HIV May Not Worsen COVID-19 Outcomes

Source: COVID-19 And HIV Jul 05, 2020 3 years ago

COVID-19 And HIV: Individuals with HIV who were hospitalized with COVID-19 did not have worse results than COVID-19 patients without HIV, according to new research by Icahn School of Medicine at Mount Sinai. The research findings were published in the journal: Clinical Infectious Diseases https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa880/5864410?searchresult=1 Study...

HIV Drugs: US FDA Approves Rukobia (Fostemsavir) To Treat Patients With Multidrug Resistant HIV Infection

Source: HIV Drugs Jul 04, 2020 3 years ago

HIV Drugs: The drug Rukobia (fostemsavir) has been approved by The U.S. FDA for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations. Rukobia (Fostemsavir) is a new type of antiretroviral medication to be taken twice daily by mouth. It is a prodrug, whi...

BREAKING NEWS! HIV: Study Shows New HIV Drug Lenacapavir Taken Once Every Six Months Can Maintain Low Viral Loads Effectively

Source: HIV and Lenacapavir Jul 02, 2020 3 years ago

HIV and Lenacapavir: Gilead scientists are reporting an early step toward an HIV drug that could potentially be taken only a couple of times per year. A new study showed that a single injection of the experimental drug, called lenacapavir, was able to lower blood levels of HIV in a small group of patients. And it was capable of maintaining active levels in the blood for more than six...

HIV: Research From Emory University Shows That New Adjuvant 3M-052 Extends Immunity Against HIV

Source: Thailand HIV Jun 21, 2020 4 years ago

HIV: Immunology researchers from the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. The research findings are published today in the journal: Science Immunology. https://immunology.sciencemag.org/content/5/48/eabb1025 Significantly, in this pre-clinical study&n...

HIV Can Harbor In Brain Cells According To Latest Study

Source: Thailand HIV Jun 12, 2020 4 years ago

HIV: Medical researchers from Rush University Medical Center, Temple University School of Medicine and the University Of Texas Medical Branch have found that astrocytes, a type of brain cell can harbor HIV and then spread the virus to immune cells that traffic them out of the brain and into other organs. It was observed that HIV moved from the brain via this route even when the virus was ...

HIV Research: CD127 Proteins Identified As Sites Of Latent Reservoirs Of HIV

Source: HIV Research May 09, 2020 4 years ago

HIV Research: Medical researchers have known for a long time that despite the advancements in antiretroviral therapy, varying amounts HIV virus remains in infected individuals forever, hiding in small reservoirs of cells of the immune system. Should ever these individuals discontinue the antiretroviral therapy, the HIV virus almost always rebounds rapidly from the reservoirs, causing deadly sympto...

New Study Shows That Vitamin E Can Treat Non-alcoholic Steatohepatitis (NASH) In HIV Patients

Source : Thailand Medical News Feb 19, 2020 4 years ago

Non-alcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver inflammation and cell damage. It is a potentially dangerous condition that can progress to cirrhosis or liver cancer. Unfortunately, HIV patients tend to have a high prevalence of the disease. A new study by McGill University, Canada has found that Vitamin E can ...

German Researchers Develop Less Toxic And More Effective HIV Treatment Using Broadly Neutralizing Antibodies That Also Prevent Viral Resistance

Source: Thailand Medical News Feb 01, 2020 4 years ago

Typically antiretroviral drugs are the gold standard for the treatment of HIV infection. They are highly effective in suppressing replication of the virus but require lifelong daily application and can be associated with side effects. Due to the high mutability of HIV and its capacity for rapid adaptation, combinations of antiretroviral agents are required to prevent the development of drug resist...

HIV Breakthrough: Researchers Reverse HIV Latency Paving Way For Potential Cure

Source: Thailand Medical News Jan 23, 2020 4 years ago

More than 42 million people are infected with HIV worldwide, about 1.5 million people in the United States alone. Currently, people with HIV take antiretroviral therapy (ART), which can suppress HIV to undetectable levels in blood, but the virus persists throughout the body in latently infected resting CD4+ T cells. The immune system cannot recognize these cells and no current therapies can elimin...

New Study On Understanding Mechanisms Of Antiviral Drugs Sheds Light of Ways to Develop Newer Anti-Resistant Drugs For HIV And Hepatitis B

Source: Thailand Medical News Jan 09, 2020 4 years ago

A research discovery by Florida State University College of Medicine researchers is expected to open the door for new and more potent treatment options for many of the more than 45 million people worldwide infected with the HIV virus and for others chronically ill with hepatitis B. Professor Dr Zucai Suo of the FSU College of Medicine. Credit: Colin Hackley/FSU Their study has established for t...

Study By Oregon Health & Science University Shows That Single Dose Of Antibodies Can Knock Out HIV In Newborns

Source: Thailand Medical News Jan 07, 2020 4 years ago

New nonhuman primate research suggests for the first time that a single dose of an antibody-based treatment can prevent HIV transmission from mother to baby. The findings are being published in the journal Nature Communications. The time or period when that single dose is given is key, however. The study found rhesus macaque newborns did not develop the monkey form of HIV, called SHIV, whe...

Despite Early Treatment, HIV Still Attacks Brains Of Young Children

Source: Thailand Medical News Dec 18, 2019 4 years ago

Despite early antiretroviral therapy, or ART, has ensured less deadly outcomes for children living with and exposed to HIV, studies show the virus still may affect the brain. HIV may disrupt neurodevelopment, affecting how children learn, reason and function. Dr Michael Boivin, professor and director of the Psychiatry Research Program in the Michigan State University College of Osteopathic Medi...

Spread Of HIV In Human Tissues Can Be Reduced By Vesicles Secreted By Certain Bacteria Strains

Source: Thailand Medical News Dec 12, 2019 4 years ago

A study of human cells and tissues by researchers at the National Institutes of Health and the University of Bologna, Italy has shown that Nano-sized vesicles released by certain bacteria that inhabit the vagina may protect against HIV infection. Typically known as extracellular vesicles, these bubble-like particles are produced by many kinds of cells and are thought to transport molecules...

Research Indicates That Babies Born With HIV Should Start Antiretrovirals Immediately

Source: Thailand Medical News Nov 30, 2019 4 years ago

For babies are born with HIV, starting treatment within hours to days is critical and important according to a new study led by researchers from Harvard. Unfortunately the norm in many countries is to wait for weeks or even months. The study findings, from a small but unique study in Botswana, could influence care in Africa and other regions hit hard by the virus. They also might offer a ...

Scripps Research, California Releases Promising Results From Experimental HIV Vaccine

Source: Thailand Medical News Nov 25, 2019 4 years ago

Researchers at Scripps Research, California and the nonprofit vaccine research organization IAVI who are developing an experimental HIV vaccine has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains. The tests, in animal models,showed that these “broadly neutralizing” antibodies, or bnAbs, targeted at least two critical sites on ...

HIV Patients And Even Doctors Not Aware Of Past Study That Links HIV With Break Down Of Intestinal Lining

Source: Thailand Medical News Nov 21, 2019 4 years ago

Despite a few past research studies that links HIV with 'erosion" of the gut's intestinal linings, leading to inflammation and also the ‘leaky gut” syndrome, many HIV patients and even doctors are not aware of this. In one past research in 2014, researchers at University of California, Davis had made some surprising discoveries about the body's initial response...

Study Shows Those With HIV Are At High Risk Of Sudden Cardiac Deaths

Source: Thailand Medical News Nov 15, 2019 4 years ago

In a study by researchers from Johns Hopkins University School of Medicine comparing medical information from portable EKG patch data from men living with HIV and also men without it, the researchers report they have found more variability of the electrical "reset" period between heartbeats known as the QT interval in men living with the virus, which may contribute to the increased...

Study Shows That Women With HIV Experience Menopause Earlier

Source: Thailand Medical News Nov 11, 2019 4 years ago

A new study demonstrates that women with HIV are more likely to enter the menopause transition at an average age of 48 years, 3 years younger than the general population. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS). Typically, newly diagnosed HIV-positive patients who adhere to the latest therapy protocols are expected to...

Interesting Reads

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 6 months ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 9 months ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 10 months ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 2 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 3 years ago

BREAKING! COVID-19 Symptoms: King’s College London and Massachusetts General Hospital Identify Six Specific Symptom Cluster ‘Types’ Of COVID-19 Infections.

Source: COVID-19 Symptoms
Jul 20, 2020 3 years ago

BREAKING NEWS! COVID-19 Alert: Research Led By Cedars-Sinai Indicates That Proton Pump Inhibitors (PPIs) Use Is Linked To Increased Risk Of COVID-19

Source: COVID-19 Alert
Jul 08, 2020 3 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 3 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 3 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 3 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 4 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 4 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 4 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 4 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 4 years ago

MOST READ

Interesting Reads